Your browser doesn't support javascript.
loading
Advancing Drug Development in Idiopathic Pulmonary Fibrosis: Tomorrow Is Now.
Khor, Yet H; Ryerson, Christopher J.
Affiliation
  • Khor YH; Respiratory Research@Alfred.
  • Ryerson CJ; School of Translational Medicine Monash University Melbourne, Victoria, Australia.
Am J Respir Crit Care Med ; 209(9): 1060-1062, 2024 05 01.
Article in En | MEDLINE | ID: mdl-38484134
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis / Drug Development Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2024 Document type: Article
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Idiopathic Pulmonary Fibrosis / Drug Development Limits: Humans Language: En Journal: Am J Respir Crit Care Med Journal subject: TERAPIA INTENSIVA Year: 2024 Document type: Article